|
Jun 13
|
AbbVie Secures FDA Approval to Expand Mavyret’s Label
|
|
Jun 13
|
FDA approves label expansion of AbbVie hepatitis C therapy
|
|
Jun 12
|
Senators Propose Ban on Drug Advertising to Consumers
|
|
Jun 12
|
AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C
|
|
Jun 11
|
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
|
|
Jun 11
|
U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus
|
|
Jun 10
|
Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?
|
|
Jun 9
|
1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
|
|
Apr 19
|
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 18
|
Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?
|
|
Apr 18
|
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
|
Apr 17
|
AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025
|
|
Apr 16
|
AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now
|
|
Apr 16
|
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
|
|
Apr 16
|
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
|
|
Apr 15
|
Top Research Reports for AbbVie, TJX & Charles Schwab
|
|
Apr 15
|
AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In
|
|
Apr 15
|
The Zacks Analyst Blog Merck and AbbVie
|
|
Apr 14
|
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
|